心臓バイオマーカー診断キットの世界市場2020-2026:製品種類別(試薬・キット、機器、化学発光、免疫蛍光法、Elisa法・免疫クロマトグラフィー)、疾患徴候別、エンドユーザー別、地域別

◆英語タイトル:Global Cardiac Biomarker Diagnostic Kits Market Size study, by Product Type (Reagents and Kits, Instruments, Chemiluminescence, Immunofluorescence, Elisa and Immunochromatography), by Disease Indication (Angina pectoris, Myocardial infraction, Cardiac heart failure and others)by End User (Hospital, Diagnostic Center, clinic and Others) and Regional Forecasts 2020-2026
◆商品コード:BZW20JN001
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2020年4月10日
◆ページ数:約200
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥514,800見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥650,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、心臓バイオマーカー診断キットの世界市場について調査・分析し、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、製品種類別(試薬・キット、機器、化学発光、免疫蛍光法、Elisa法・免疫クロマトグラフィー)分析、疾患徴候別分析、エンドユーザー別分析、地域別分析、競争状況などを含め、次の構成でお届け致します。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・心臓バイオマーカー診断キットの世界市場:製品種類別(試薬・キット、機器、化学発光、免疫蛍光法、Elisa法・免疫クロマトグラフィー)
・心臓バイオマーカー診断キットの世界市場:疾患徴候別
・心臓バイオマーカー診断キットの世界市場:エンドユーザー別
・心臓バイオマーカー診断キットの世界市場:地域別
・競争状況
【レポートの概要】

Global Cardiac Biomarker Diagnostic Kits Market is valued approximately USD 2.33 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 5.4% over the forecast period 2019-2026. Cardiac Biomarker diagnostic kits is a subset of tools and instruments those are used to measure and evaluate heart functions. It has remarkable role in early prediction or diagnosis of heart related diseases. It has favorable benefits in early prediction of heart diseases and has capable of evaluating significant cure or treatment of cardiovascular diseases. Therefore, increasing prevalence of cardiovascular diseases across the globe is the factor attributed to drive the growth of market over the forecast years. For instance: As per the World Health Organization, Cardiovascular diseases are estimated as the primary reason of death due to disease across the globe which accounts for over 17.9 million, 31% of worldwide death each year due to cardiovascular disease. It is estimated that more than 75% of deaths occurred through cardiovascular disease is emerged in low and middle-income countries and over 85% of deaths are taking place due to sever heart attacks and strokes. In Addition, increasing geriatric population across the globe in emerging economies is expected to fuel the lucrative thrust to the growth of market over the upcoming year 2020-2026. However, high cost of cardiac biomarker diagnostic kits in emerging economies would expect to hamper the growth of market over the forthcoming period.

The regional analysis of global Cardiac Biomarker Diagnostic Kits market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the growth in disposable income of the population along with increasing investment in healthcare sector in the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026. Factors such as rapid growth in cardiovascular diseases and ageing population in the region would create lucrative growth prospects for the Cardiac Biomarker Diagnostic Kits market across Asia-Pacific region.

Major market player included in this report are:
Roche Diagnostics Limited
Abbott Laboratories
Siemens AG
Danaher Corporation
Biomérieux SA
Alere Inc.
LSI Medience Corporation
Ortho Clinical Diagnostics
Randox Laboratories Ltd.
Guangzhou Wondfo Biotech Co., Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type:
Reagents and Kits
Instruments
Chemiluminescence
Immunofluorescence
Elisa
Immunochromatography
By Disease Indication:
Angina Pectoris
Myocardial Infraction
Cardiac Heart Failure
Others

By End-User:
Hospitals
Diagnostic Centers
Clinics
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017, 2018
Base year – 20198
Forecast period – 2020 to 2026

Target Audience of the Global Cardiac Biomarker Diagnostic Kits Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Billion)
1.2.1. Cardiac Biomarker Diagnostic Kit Market, by Region, 2018-2026 (USD Billion)
1.2.2. Cardiac Biomarker Diagnostic Kit Market, by Product Type, 2018-2026 (USD Billion)
1.2.3. Cardiac Biomarker Diagnostic Kit Market, by Diseases Indication, 2018-2026 (USD Billion)
1.2.4. Cardiac Biomarker Diagnostic Kit Market, by End-User, 2018-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Cardiac Biomarker Diagnostic Kit Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Cardiac Biomarker Diagnostic Kit Market Dynamics
3.1. Cardiac Biomarker Diagnostic Kit Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Cardiac Biomarker Diagnostic Kit Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Cardiac Biomarker Diagnostic Kit Market, by Product Type
5.1. Market Snapshot
5.2. Global Cardiac Biomarker Diagnostic Kit Market by Product Type, Performance – Potential Analysis
5.3. Global Cardiac Biomarker Diagnostic Kit Market Estimates & Forecasts by Product Type 2016-2026 (USD Billion)
5.4. Cardiac Biomarker Diagnostic Kit Market, Sub Segment Analysis
5.4.1. Reagents and Kits
5.4.2. Instruments
5.4.3. Chemiluminescence
5.4.4. Immunofluorescence
5.4.5. Elisa
5.4.6. Immunochromatography
Chapter 6. Global Cardiac Biomarker Diagnostic Kit Market, by Diseases Indication
6.1. Market Snapshot
6.2. Global Cardiac Biomarker Diagnostic Kit Market by Diseases Indication, Performance – Potential Analysis
6.3. Global Cardiac Biomarker Diagnostic Kit Market Estimates & Forecasts by Diseases Indication 2016-2026 (USD Billion)
6.4. Cardiac Biomarker Diagnostic Kit Market, Sub Segment Analysis
6.4.1. Angina Pectoris
6.4.2. Myocardial Infraction
6.4.3. Cardiac Heart Failure
6.4.4. Others
Chapter 7. Global Cardiac Biomarker Diagnostic Kit Market, by End-User
7.1. Market Snapshot
7.2. Global Cardiac Biomarker Diagnostic Kit Market by End-User, Performance – Potential Analysis
7.3. Global Cardiac Biomarker Diagnostic Kit Market Estimates & Forecasts by End-User 2016-2026 (USD Billion)
7.4. Cardiac Biomarker Diagnostic Kit Market, Sub Segment Analysis
7.4.1. Hospitals
7.4.2. Diagnostic Centres
7.4.3. Clinics
7.4.4. Others
Chapter 8. Global Cardiac Biomarker Diagnostic Kit Market, Regional Analysis
8.1. Cardiac Biomarker Diagnostic Kit Market, Regional Market Snapshot
8.2. North America Cardiac Biomarker Diagnostic Kit Market
8.2.1. U.S. Cardiac Biomarker Diagnostic Kit Market
8.2.1.1. Product Type breakdown estimates & forecasts, 2016-2026
8.2.1.2. Diseases Indication breakdown estimates & forecasts, 2016-2026
8.2.1.3. End-User breakdown estimates & forecasts, 2016-2026
8.2.2. Canada Cardiac Biomarker Diagnostic Kit Market
8.3. Europe Cardiac Biomarker Diagnostic Kit Market Snapshot
8.3.1. U.K. Cardiac Biomarker Diagnostic Kit Market
8.3.2. Germany Cardiac Biomarker Diagnostic Kit Market
8.3.3. Rest of Europe Cardiac Biomarker Diagnostic Kit Market
8.4. Asia-Pacific Cardiac Biomarker Diagnostic Kit Market Snapshot
8.4.1. China Cardiac Biomarker Diagnostic Kit Market
8.4.2. India Cardiac Biomarker Diagnostic Kit Market
8.4.3. Japan Cardiac Biomarker Diagnostic Kit Market
8.4.4. Rest of Asia Pacific Cardiac Biomarker Diagnostic Kit Market
8.5. Latin America Cardiac Biomarker Diagnostic Kit Market Snapshot
8.5.1. Brazil Cardiac Biomarker Diagnostic Kit Market
8.5.2. Mexico Cardiac Biomarker Diagnostic Kit Market
8.6. Rest of The World Cardiac Biomarker Diagnostic Kit Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Roche Diagnostics Limited
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Abbott Laboratories
9.2.3. Siemens AG
9.2.4. Danaher Corporation
9.2.5. Biomérieux SA
9.2.6. Alere Inc.
9.2.7. LSI Medience Corporation
9.2.8. Ortho Clinical Diagnostics
9.2.9. Randox Laboratories Ltd.
9.2.10. Guangzhou Wondfo Biotech Co., Ltd.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

List of Tables
TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET
TABLE 3. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
TABLE 7. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY PRODUCT TYPE 2016-2026 (USD BILLION)
TABLE 8. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY DISEASES INDICATION 2016-2026 (USD BILLION)
TABLE 9. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY END-USER 2016-2026 (USD BILLION)
TABLE 10. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 11. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 12. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 13. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 14. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 15. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 16. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 17. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 18. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 19. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 20. U.S. CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 21. U.S. CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 22. U.S. CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 23. CANADA CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 24. CANADA CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 25. CANADA CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 26. UK CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 27. UK CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 28. UK CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 29. GERMANY CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 30. GERMANY CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 31. GERMANY CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 32. ROE CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 33. ROE CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 34. ROE CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 35. CHINA CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 36. CHINA CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 37. CHINA CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 38. INDIA CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 39. INDIA CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 40. INDIA CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 41. JAPAN CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 42. JAPAN CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 43. JAPAN CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 44. ROAPAC CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 45. ROAPAC CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 46. ROAPAC CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 47. BRAZIL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 48. BRAZIL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 49. BRAZIL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 50. MEXICO CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 51. MEXICO CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 52. MEXICO CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 53. ROLA CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 54. ROLA CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 55. ROLA CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 56. ROW CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 57. ROW CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 58. ROW CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[心臓バイオマーカー診断キットの世界市場2020-2026:製品種類別(試薬・キット、機器、化学発光、免疫蛍光法、Elisa法・免疫クロマトグラフィー)、疾患徴候別、エンドユーザー別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆